José Cordero-Ampuero , Paula Velasco , Jorge Payo-Rodríguez , Pablo Peñalver-Andrada , Enrique González-Fernández
{"title":"全羟基磷灰石涂层全髋关节置换术中的陶瓷对陶瓷与金属对交联聚乙烯:存活率、并发症和长期效果","authors":"José Cordero-Ampuero , Paula Velasco , Jorge Payo-Rodríguez , Pablo Peñalver-Andrada , Enrique González-Fernández","doi":"10.1016/j.jcot.2024.102555","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Few studies compare complications and results in ceramic-ceramic (CeCe) <em>vs</em> metal-on-crosslink polyethylene (Me-XLPE) hip prosthesis.</div></div><div><h3>Methods</h3><div><strong>Prospective, non-randomized, observational analysis</strong> of 2 series of hydroxyapatite-coated Furlong Active implanted with identical protocol by 1 surgeon in 1 hospital from 2006 to 2014.</div></div><div><h3>Bearing surface</h3><div>CeCe (Biolox Forte/Delta) in 35 cases of 53.7 ± 10.6 years (25–69) (21 males, 60 %), Me-XLPE in 65 of 69.0 ± 8.9 years (42–81) (36 males, 55 %); age was different (p < 0.00001), but not sex (p = 0.6565). Head diameter: 28 mm in 19, 32 mm in 9 and 36 mm in 7 CeCe hips; 28 mm in 63, 32 mm in 1 and 36 mm in 1 Me-XLPe hips.</div></div><div><h3>Follow-up</h3><div>10.5 ± 3.1 years (1–15) in ceramic, 9.8 ± 3.8 years (2–15) in Me-XLPE.</div></div><div><h3>Results</h3><div>Survivorship without additional surgery or closed reduction at 15 years: 91.0 % in ceramic, 83.8 % in Me-XLPE joints. Survivorship without component exchange at 15 years: 93.9 % in ceramic, 93.6 % in Me-XLPE joints.</div></div><div><h3>Complications</h3><div>CeCe joints suffered 2 infections, 1 isolated dislocation, and 1 Vancouver-C fracture. Me-XLPE joints presented 2 infections (p = 0.6101), 5 isolated (p = 0.6621) and 2 recurrent dislocations (p = 0.5454), and 4 Vancouver-B fractures (p = 0.6548).</div><div>At final follow-up, Harris Hip Score averaged 93.2 ± 13.7 (23–100) in ceramic and 94.3 ± 8.7 (65–100) in XLPE joints (p = 0.64552).</div><div>Measured radiographic wear reached 0.06 ± 0.38 mm (0–1.5) (0.0057 mm/year) in CeCe and 0.16 ± 0.5 mm (0–2) (0.0163 mm/year) in Me-XLPE (p = 0.30302). At final radiographic follow-up, osteolysis was present in 8 Charnley-De Lee zones (6 patients) (17 %) of ceramic cups and in 25 zones (15 patients) (23 %) of XLPE cups (p = 0.980127).</div></div><div><h3>Conclusion</h3><div>At 10 years follow-up, metal-XLPE and ceramic-ceramic joints in Furlong-H-A.C. Active present no significant differences in complications, clinical score, wear, acetabular osteolysis, or survivorship without component exchange.</div><div>Nevertheless, survivorship without any surgery or closed reduction is different because of the high rate of dislocation in 28 mm metal-poly joints.</div></div>","PeriodicalId":53594,"journal":{"name":"Journal of Clinical Orthopaedics and Trauma","volume":"57 ","pages":"Article 102555"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ceramic-on-ceramic vs metal-on-crosslink polyethylene in a fully hydroxyapatite-coated total hip arthroplasty: Survivorship, complications and long-term results\",\"authors\":\"José Cordero-Ampuero , Paula Velasco , Jorge Payo-Rodríguez , Pablo Peñalver-Andrada , Enrique González-Fernández\",\"doi\":\"10.1016/j.jcot.2024.102555\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Few studies compare complications and results in ceramic-ceramic (CeCe) <em>vs</em> metal-on-crosslink polyethylene (Me-XLPE) hip prosthesis.</div></div><div><h3>Methods</h3><div><strong>Prospective, non-randomized, observational analysis</strong> of 2 series of hydroxyapatite-coated Furlong Active implanted with identical protocol by 1 surgeon in 1 hospital from 2006 to 2014.</div></div><div><h3>Bearing surface</h3><div>CeCe (Biolox Forte/Delta) in 35 cases of 53.7 ± 10.6 years (25–69) (21 males, 60 %), Me-XLPE in 65 of 69.0 ± 8.9 years (42–81) (36 males, 55 %); age was different (p < 0.00001), but not sex (p = 0.6565). Head diameter: 28 mm in 19, 32 mm in 9 and 36 mm in 7 CeCe hips; 28 mm in 63, 32 mm in 1 and 36 mm in 1 Me-XLPe hips.</div></div><div><h3>Follow-up</h3><div>10.5 ± 3.1 years (1–15) in ceramic, 9.8 ± 3.8 years (2–15) in Me-XLPE.</div></div><div><h3>Results</h3><div>Survivorship without additional surgery or closed reduction at 15 years: 91.0 % in ceramic, 83.8 % in Me-XLPE joints. Survivorship without component exchange at 15 years: 93.9 % in ceramic, 93.6 % in Me-XLPE joints.</div></div><div><h3>Complications</h3><div>CeCe joints suffered 2 infections, 1 isolated dislocation, and 1 Vancouver-C fracture. Me-XLPE joints presented 2 infections (p = 0.6101), 5 isolated (p = 0.6621) and 2 recurrent dislocations (p = 0.5454), and 4 Vancouver-B fractures (p = 0.6548).</div><div>At final follow-up, Harris Hip Score averaged 93.2 ± 13.7 (23–100) in ceramic and 94.3 ± 8.7 (65–100) in XLPE joints (p = 0.64552).</div><div>Measured radiographic wear reached 0.06 ± 0.38 mm (0–1.5) (0.0057 mm/year) in CeCe and 0.16 ± 0.5 mm (0–2) (0.0163 mm/year) in Me-XLPE (p = 0.30302). At final radiographic follow-up, osteolysis was present in 8 Charnley-De Lee zones (6 patients) (17 %) of ceramic cups and in 25 zones (15 patients) (23 %) of XLPE cups (p = 0.980127).</div></div><div><h3>Conclusion</h3><div>At 10 years follow-up, metal-XLPE and ceramic-ceramic joints in Furlong-H-A.C. Active present no significant differences in complications, clinical score, wear, acetabular osteolysis, or survivorship without component exchange.</div><div>Nevertheless, survivorship without any surgery or closed reduction is different because of the high rate of dislocation in 28 mm metal-poly joints.</div></div>\",\"PeriodicalId\":53594,\"journal\":{\"name\":\"Journal of Clinical Orthopaedics and Trauma\",\"volume\":\"57 \",\"pages\":\"Article 102555\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Orthopaedics and Trauma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0976566224002248\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Orthopaedics and Trauma","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0976566224002248","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Ceramic-on-ceramic vs metal-on-crosslink polyethylene in a fully hydroxyapatite-coated total hip arthroplasty: Survivorship, complications and long-term results
Background
Few studies compare complications and results in ceramic-ceramic (CeCe) vs metal-on-crosslink polyethylene (Me-XLPE) hip prosthesis.
Methods
Prospective, non-randomized, observational analysis of 2 series of hydroxyapatite-coated Furlong Active implanted with identical protocol by 1 surgeon in 1 hospital from 2006 to 2014.
Bearing surface
CeCe (Biolox Forte/Delta) in 35 cases of 53.7 ± 10.6 years (25–69) (21 males, 60 %), Me-XLPE in 65 of 69.0 ± 8.9 years (42–81) (36 males, 55 %); age was different (p < 0.00001), but not sex (p = 0.6565). Head diameter: 28 mm in 19, 32 mm in 9 and 36 mm in 7 CeCe hips; 28 mm in 63, 32 mm in 1 and 36 mm in 1 Me-XLPe hips.
Follow-up
10.5 ± 3.1 years (1–15) in ceramic, 9.8 ± 3.8 years (2–15) in Me-XLPE.
Results
Survivorship without additional surgery or closed reduction at 15 years: 91.0 % in ceramic, 83.8 % in Me-XLPE joints. Survivorship without component exchange at 15 years: 93.9 % in ceramic, 93.6 % in Me-XLPE joints.
At final follow-up, Harris Hip Score averaged 93.2 ± 13.7 (23–100) in ceramic and 94.3 ± 8.7 (65–100) in XLPE joints (p = 0.64552).
Measured radiographic wear reached 0.06 ± 0.38 mm (0–1.5) (0.0057 mm/year) in CeCe and 0.16 ± 0.5 mm (0–2) (0.0163 mm/year) in Me-XLPE (p = 0.30302). At final radiographic follow-up, osteolysis was present in 8 Charnley-De Lee zones (6 patients) (17 %) of ceramic cups and in 25 zones (15 patients) (23 %) of XLPE cups (p = 0.980127).
Conclusion
At 10 years follow-up, metal-XLPE and ceramic-ceramic joints in Furlong-H-A.C. Active present no significant differences in complications, clinical score, wear, acetabular osteolysis, or survivorship without component exchange.
Nevertheless, survivorship without any surgery or closed reduction is different because of the high rate of dislocation in 28 mm metal-poly joints.
期刊介绍:
Journal of Clinical Orthopaedics and Trauma (JCOT) aims to provide its readers with the latest clinical and basic research, and informed opinions that shape today''s orthopedic practice, thereby providing an opportunity to practice evidence-based medicine. With contributions from leading clinicians and researchers around the world, we aim to be the premier journal providing an international perspective advancing knowledge of the musculoskeletal system. JCOT publishes content of value to both general orthopedic practitioners and specialists on all aspects of musculoskeletal research, diagnoses, and treatment. We accept following types of articles: • Original articles focusing on current clinical issues. • Review articles with learning value for professionals as well as students. • Research articles providing the latest in basic biological or engineering research on musculoskeletal diseases. • Regular columns by experts discussing issues affecting the field of orthopedics. • "Symposia" devoted to a single topic offering the general reader an overview of a field, but providing the specialist current in-depth information. • Video of any orthopedic surgery which is innovative and adds to present concepts. • Articles emphasizing or demonstrating a new clinical sign in the art of patient examination is also considered for publication. Contributions from anywhere in the world are welcome and considered on their merits.